Dr. Elizabeth A. Guancial, MD

Dr. Guancial practices at Sarasota Memorial Hospital - Sarasota Campus in Sarasota, Florida, part of Sarasota Memorial Health Care System.

Dr. Guancial's NPI, 1124155569, was assigned on February 27, 2007. Dr. Guancial graduated from Harvard Medical School in 2006. Dr. Guancial holds Florida license ME135035.

Dr. Guancial's primary practice is Sarasota Memorial Hospital - Sarasota Campus, at 1700 S Tamiami Trl, Sarasota, FL 34239 in Sarasota County. The practice phone is (941) 917-9000.

Dr. Guancial's primary practice is Sarasota Memorial Hospital - Sarasota Campus in Sarasota, Florida, part of Sarasota Memorial Health Care System. Dr. Guancial is also affiliated with Sarasota Memorial Hospital-Venice. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Guancial to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Guancial practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Guancial's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Guancial is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Guancial's licenses on file in 3 states: Florida, New York and Massachusetts.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Guancial treats.

CMS data shows 223,449 Medicare services from Dr. Guancial across 54 procedure codes in 2024, for 849 Medicare patients. Medicare paid $4,939,812 for them. Every service was in an office.

CMS counts 849 Medicare patients who saw Dr. Guancial in 2024. The largest group is 75 to 84, with 395 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Guancial's median patient age at 70, with 51% women.

In 2024, Dr. Guancial wrote 1,397 Medicare Part D claims for 266 patients. 70% of them were for generic drugs. CMS names the drug for 1,171 of them, across 29 drugs with 11 or more claims each, at $4,716,164 in total drug cost. In 2023, CMS named 953 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Guancial for performance year 2024, reported as part of a group. Dr. Guancial accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Guancial as offering telehealth.

Dmand AI links 32 papers to Dr. Guancial, published from 2006 to 2020. 2014 was the busiest year, with 5. The most frequent topics are Urinary Bladder Neoplasms, Carcinoma, Transitional Cell and Neoplasm Metastasis. Dr. Guancial has published most often in Clin Genitourin Cancer. Dr. Guancial's most frequent co-authors are Jonathan Eric Rosenberg, MD, Toni K. Choueiri, MD and Deepak M. Sahasrabudhe, MD.

Dmand AI links Dr. Guancial to 6 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Carcinoma, Transitional Cell, Urinary Bladder Neoplasms and Fallopian Tube Diseases.

CMS Open Payments shows 274 general payments to Dr. Guancial from 41 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Genentech, Inc. paid the most, $45,253.

Dmand AI lists 1 award for Dr. Guancial, most recently CMS Stage 1 EHR in 2014.

Dr. Guancial graduated from Harvard Medical School in 2006. Dr. Guancial is a member of ASCO.

Dr. Guancial is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.